>> 全站文章索引 >> 第34页:
  • Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice - [Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B.]
  • High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains - [P. Rosel, B. Arranz, J. Vallejo, M. Oros, J. M. Menchón, P. Alvarez, M. A. Navarro]
  • Peripheral Markers of Serotonergic and Noradrenergic Function in Post-Pubertal, Caucasian Males with Autistic Disorder - [Jan Croonenberghs1 MD, Laure Delmeire2 MD, Robert Verkerk3 Ph.D, Ai-hua Lin2,3 MD, MSci, Anisa Meskal5 Ph.D, Hugo Neels5 Ph.D, Marc Van der Planken6 MD, Ph.D, Simon Scharpe3 Ph.D, Dirk Deboutte1 MD, Ph.D, Greet Pison4 Ph.D and Michael Maes2,7,8,9 MD, Ph.D]
  • Serotonergic and Noradrenergic Markers of Post-Traumatic Stress Disorder with and without Major Depression - [Michael Maes1,2,3 MD, Ph.D, Ai-hua Lin1 MD, MSci, Robert Verkerk4 Ing, Laure Delmeire1 MD, An Van Gastel MD, Marc Van der Planken5 MD, Ph.D and Simon Scharpé4 Ph.D]
  • Co-catalyzed reductive cyclization of azido and cyano substituted α,β-unsaturated esters with NaBH4: enantioselective synthesis of ?-baclofen and ?-rolipram - [Abhimanyu S. Paraskar and Arumugam Sudalai]
  • Social anxiety disorder assessment and pharmacological management - [I. Figueira, R. Jacques]
  • Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment - [N. Brunello, J. A. den Boer, L. L. Judd, S. Kasper, J. E. Kelsey, M. Lader, Y. Lecrubier, J. P. Lepine, R. B. Lydiard, J. Mendlewicz, et al.]
  • Social anxiety disorder under scrutiny - [Jonathan R.T. Davidson, M.D. * AD:Department of Psychiatry and Behavioral Science, Duke University Medical Center, Durham, North Carolina]
  • Pharmacological approaches to smoking cessation - [Mitrouska I, Bouloukaki I, Siafakas NM.]
  • Antidepressant treatment of the depressed patient with insomnia - [Thase ME.]
  • EEG correlates of acute and chronic paroxetine treatment in depression - [Verner Knott, Colleen Mahoney, Sidney Kennedy and Kenneth Evans]
  • Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel? - [Pal Pacher, Valeria Kecskemeti]
  • Antidepressants: past, present and future - [Jerzy Vetulani and Irena Nalepa]
  • A Single Dose of the Serotonin Neurotransmission Agonist Paroxetine Enhances Motor Output: Double-Blind, Placebo-Controlled, fMRI Study in Healthy Subjects - [Isabelle Loubinoux, Jérémie Pariente, Kader Boulanouar, Christophe Carel, Claude Manelfe, Olivier Rascol, Pierre Celsis and Fran?ois Chollet]
  • Manifestations of West Nile neuroinvasive disease - [Sejvar JJ, Marfin AA.]
  • Paroxetine influences respiration in rats: implications for the treatment of panic disorder - [Marie Olsson, Kristina Annerbrink, Finn Bengtsson, Jan Hedner and Elias Eriksson]
  • Paroxetine influences respiration in rats, Implications for the treatment of panic disorder - [Olsson M, Annerbrink K, Bengtsson F, Hedner J, Eriksson E]
  • The effects of antidepressant drug treatments on activator protein-1 binding activity in the rat brain - [Tatsuji Tamura, Shigeru Morinobu, Yasumasa Okamoto, Ariyuki Kagaya and Shigeto Yamawaki]
  • Effects of Hypericum perforatum and paroxetine in the mouse defense test battery - [Vanessa Beijamini and Roberto Andreatini]
  • The Corticosteroid Receptor Hypothesis of Depression - [Florian Holsboer MD, Ph.D]
  • Implication of abnormal epigenetic patterns for human diseases - [Santos-Rebou?as CB, Pimentel MM.]
  • Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial - [Zbigniew Zylicz, Malgorzata Krajnik, Adriaan Alistar van Sorge and Massimo Costantini]
  • Antidepressant-like effects in various mice strains in the tail suspension test - [Nadège Ripoll, Denis Joseph Paul David, Eric Dailly, Martine Hasco?t and Michel Bourin]
  • Effects of Endogenous Neurotransmitters on the in vivo Binding of Dopamine and 5-HT Radiotracers in Mice - [Onarae V Rice1 MA, S John Gatley1 Ph.D, Ji Shen1 Ph.D, Craig L Huemmer1 BS, Renata Rogoz1 Ph.D, Onofre T DeJesus2 Ph.D, Nora D Volkow1 MD and Andrew N Gifford1 Ph.D]
  • Separation of five recently commercialized selective serotonin reuptake inhibitor antidepressants by capillary electrophoresis - [Vincenzo Pucci 1, Salvatore Fanali 2, Cesare Sabbioni 1, Maria Augusta Raggi * AD:1University of Bologna, Department of Pharmaceutical Sciences, Via Belmeloro 6, 40126 Bologna, Italy; Fax: +39 051 20997342National Council of Research, Institute of Chemist]
  • Local 5,7-Dihydroxytryptamine Lesions of Rat Amygdala: Release of Punished Drinking, Unaffected Plus-Maze Behavior and Ethanol Consumption - [Wolfgang Sommer1 MD, Ph.D, Christian Moller1 MD, Ph.D, Lisa Wiklund1 BSc, Annika Thorsell1 Ph.D, Roberto Rimondini1 Ph.D, Hans Nissbrandt2 MD, Ph.D and Markus Heilig1 MD, Ph.D]
  • Are behavioral problems in childhood and adolescence associated with bipolar disorder in early adulthood - [Endrass J, Vetter S, Gamma A, Gallo WT, Rossegger A, Urbaniok F, Angst J.]
  • Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice - [Florence Clenet, Anouk De Vos and Michel Bourin]
  • The Gerbil Elevated Plus-Maze I: Behavioral Characterization and Pharmacological Validation - [Geoffrey B Varty, Cynthia A Morgan, Mary E Cohen-Williams, Vicki L Coffin, Galen J Carey]
  • Sleep in obsessive compulsive disorder:Polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency - [Voderholzer U, Riemann D, Huwig-Poppe C, Kuelz AK, Kordon A, Bruestle K, Berger M, Hohagen F.]
  • Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia - [Christoforou A, Le Hellard S, Thomson PA, Morris SW, Tenesa A, Pickard BS, Wray NR, Muir WJ, Blackwood DH, Porteous DJ, Evans KL.]
  • Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder - [E. Hernández, S. Lastra, M. Urbina, I. Carreira and L. Lima]
  • Enzymatic alkoxycarbonylation reactions on the intermediate in the synthesis of (?)-paroxetine, trans-N-benzyloxycarbonyl-4-(4′-fluorophenyl)-3-hydroxymethylpiperidine - [Gonzalo de Gonzalo, Rosario Brieva, Víctor M. Sánchez, Miguel Bayod and Vicente Gotor]
  • Decreased Neuroendocrine Responses to Meta-Chlorophenylpiperazine (m-CPP) but Normal Responses to Ipsapirone in Marathon Runners - [Andreas Broocks1 MD, Tim Meyer5 MD, Annette George2 MD, Ursula Hillmer-Vogel4 MD, Detlef Meyer1 MD, Borwin Bandelow1 MD, G?ran Hajak1 MD, Uwe Bartmann1 Ph.D, Christoph H Gleiter3 MD and Eckart Rüther1 MD]
  • Drug sales in four European countries still differ - [Silvio Garattini, Livio Garattini]
  • Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors - [M. H. Nelson, A. K. Birnbaum and R. P. Remmel]
  • Clinical implications of pharmacogenetics of antidepressants - [Koichi Otani, Kazuo Mihara, Norio Yasui-Furukori, Akihito Suzuki, Tsuyoshi Kondo and Sunao Kaneko]
  • Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. - [Richelson E]
  • Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression - [Margareta Reis 1 2 *, Anna ?berg-Wistedt 3, Hans ?gren 4, Peter H?glund 2, Ann-Charlotte ?kerblad 5, Finn Bengtsson 5 AD:1Department of Medicine and Care, Division of Clinical Pharmacology, Faculty of Health Sciences, Link?ping University, Link?ping, Swed]
  • Ionic interactions in the Drosophila serotonin transporter identify it as a serotonin channel - [Christina I. Petersen, Louis J. DeFelice]
  • 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand - [Shunichi Oya, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton, Michael Siciliano and Hank F. Kung]
  • Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens - [Nemesio Cede?o, Mary Urbina, Francisco Obregón and Lucimey Lima]
  • Decrease of Serotonin Transporters in Blood Platelets after Epileptic Seizures - [Aroldo Cupello, Emilio Favale, Daniela Audenino, Simona Scarrone, Stefania Gastaldi, Claudio Albano]
  • Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Ikuyo Motoki, Sumiko Tayoshi, Koshi Ohta, Hongwei Song, Kyoko Morita, Kazuhito Rokutan and Tetsuro Ohmori]
  • Antipanic Efficacy of Paroxetine and Polymorphism within the Promoter of the Serotonin Transporter Gene - [Giampaolo Perna1, Elisa Favaron1, Daniela Di Bella1, Riccardo Bussi1 and Laura Bellodi1]
  • Placebo-Controlled Trial Comparing Intermittent and Continuous Paroxetine in Premenstrual Dysphoric Disorder - [Mikael Landén1, Hans Nissbrandt2, Christer Allgulander3, Karin S?rvik4, Christina Ysander4 and Elias Eriksson2,4]
  • Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials - [Roja Rahimi, Shekoufeh Nikfar and Mohammad Abdollahi]
  • Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression - [Sanjaya Saxena, Arthur L Brody, Matthew L Ho, Narineh Zohrabi, et al]
  • Antidepressant-induced regulation of 5-HT1b mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation - [J.P. Anthony, T.J. Sexton, J.F. Neumaier * Department of Psychiatry and Behavioral Sciences and Harborview Medical Center, University of Washington, Seattle]
  • Electrophysiological Evidence for the Tonic Activation of 5-HT1A Autoreceptors in the Rat Dorsal Raphe Nucleus - [Nasser Haddjeri1, Normand Lavoie2 and Pierre Blier2]
  • Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with α-[14C]methyl--tryptophan - [Fumitaka Yamane, Hidehiko Okazawa, Pierre Blier and Mirko Diksic]
  • 1-(m-Chlorophenyl)piperazine (mCPP) Dissociates In Vivo Serotonin Release from Long-Term Serotonin Depletion in Rat Brain - [Michael H Baumann Ph.D, Mario A Ayestas BS, Christina M Dersch MS and Richard B Rothman MD, Ph.D]
  • Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging - [Carolyn Cidis Meltzer MD, Gwenn Smith Ph.D, Steven T DeKosky MD, Bruce G Pollock MD, Ph.D, Chester A Mathis Ph.D, Robert Y Moore MD, Ph.D, David J Kupfer MD and Charles F Reynolds III MD]
  • Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability - [Arturo Zazpe, Inés Artaiz, Luis Labeaga, María Luisa Lucero and Aurelio Orjales]
  • 5-HT1A Receptor Function in Normal Subjects on Clinical Doses of Fluoxetine: Blunted Temperature and Hormone Responses to Ipsapirone Challenge - [Bernard Lerer1 MD, Yevgenia Gelfin1 MD, Malka Gorfine2 MA, Bruno Allolio3 MD, K Peter Lesch4 MD and Michael E Newman1 Ph.D]
  • Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions - [T. A. Slotkin, F. J. Seidler and S. F. Ali]
  • The Kutcher Adolescent Depression Scale: Assessment of Its Evaluative Properties over the Course of an 8-Week Pediatric Pharmacotherapy Trial - [Sarah J. Brooks, Stanley P. Krulewicz, Stan Kutcher]
  • Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms - [David C Mamo, Robert A Sweet, Benoit H Mulsant, Bruce G Pollock, et al.]
  • A twelve-week, double-blind, Randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients - [Benoit H Mulsant, Bruce G Pollock, Robert Nebes, Mark D Miller, et al.]
  • Blockade of 5-HT1A Receptors by ()-Pindolol Potentiates Cortical 5-HT Outflow, but not Antidepressant-Like Activity of Paroxetine: Microdialysis and Behavioral Approaches in 5-HT1A Receptor Knockout Mice - [Jean-Philippe Guilloux1, Denis J P David1, Bruno P Guiard1, Franck Chenu2, Christelle Repérant1, Miklos Toth3, Michel Bourin2 and Alain M Gardier1]
  • Treatment-emergent behavioural side effects with selective serotonin re-uptake inhibitors in adults with learning disabilities - [A. B. Biswas 1 *, S. Bhaumik 1, D. Branford 2 AD:1University of Leicester, & Leicestershire and Rutland Healthcare NHS Trust, Frith Hospital, Groby Road, Leicester LE3 9QF, UK2Southern Derbyshire Mental Health Trust, Kingsway Hospital, Derby DE22 3LZ, UK]
  • Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study - [Malcolm Lader, M.D. 1 *, Karina Stender, Ph.D. 2, Vera Bürger, M.Sc. 3, Rico Nil, Ph.D. 4 AD:1Institute of Psychiatry, University of London, London, United Kingdom2H. Lundbeck A/S, Copenhagen, Denmark3Lundbeck Austria GmbH, Vienna, Austria4Lundbeck (Switz]
  • Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: A [11C] DASB PET imaging study - [Jeffrey H Meyer, Alan A Wilson, Nathalie Ginovart, Verdell Goulding, et al]
  • Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain - [Kazufumi Hirano, Takahiro Seki, Norio Sakai, Yasuhiro Kato, Hisakuni Hashimoto, Shinya Uchida and Shizuo Yamada]
  • Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography - [L. Labat, M. Deveaux, P. Dallet and J. P. Dubost]
  • Paroxetine-induced apoptosis in human osteosarcoma cells: Activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation - [Chiang-Ting Chou, Shiping He and Chung-Ren Jan]
  • Paroxetine versus citalopram treatment of pathological crying after brain injury - [Ulrich Muller, Toshiya Murai, Thomas Bauer-Wittmund, D. Yves Von Cramon]
  • Which selective serotonin reuptake inhibitor works best? - [Robert K Schneider, James L Levenson]
  • SSRIs and Ejaculation A Double-Blind, Randomized, Fixed-Dose Study With Paroxetine and Citalopram - [Waldinger MD, Zwinderman AH, Olivier B.]
  • Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats - [Trynke R. de Jong, Liselore J.A.E. Snaphaan, Tommy Pattij, Jan G. Veening, Marcel D. Waldinger, Alexander R. Cools and Berend Olivier]
  • Vardenafil reverses erectile dysfunction induced by paroxetine in rats - [J Angulo, E Bischoff, S Gabancho, P Cuevas, I Sáenz de Tejada]
  • α2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice - [Fabienne Massé, Martine Hasco?t and Michel Bourin]
  • Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study - [Murray B. Stein, G. Ron Norton, John R. Walker, Mariette J. Chartier and Roger Graham]
  • Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors - [H. Nordeng, R. Lindemann, K. V. Perminov, . Reikvam1]
  • Once-daily high-dose pindolol for SSRI-refractory depression - [Kenneth N. Sokolski, Janet C. Conney, Brenda J. Brown and Edward M. DeMet]
  • High vs Low Anxiety-Related Behavior Rats: An Animal Model of Extremes in Trait Anxiety - [Rainer Landgraf, Alexandra Wigger]
  • Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate–early gene Arc in rat brain - [R. Tordera, Q. Pei, M. Newson, K. Gray, M. Sprakes and T. Sharp]
  • Response selection in schizophrenia - [Pellizzer G, Stephane M.]
  • Normal Personality Characteristics in Schizophrenia A Review of the Literature Involving the FFM - [Dinzeo TJ, Docherty NM.]
  • Antipsychotics inhibit TREK but not TRAAK channels - [Susanne Thümmler, Fabrice Duprat and Michel Lazdunski]
  • Response styles among patients with minor depression and dysthymia in primary care - [College of Health Sciences, University of Texas at El Paso, 79902, USA. schmaling@utep.edu]
  • A Review of the Bioactivity of South African Herbal Teas Rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia) - [McKay DL, Blumberg JB.]
  • Traitement d'une intoxication à l'hydroxychloroquine par circulation extracorporelle - [F. Mongenot, Y. Tessier Gonthier, F. Derderian, M. Durand and D. Blin]
  • Récepteurs 5-HT1B de la sérotonine et effets antidépresseurs des inhibiteurs de recapture sélectifs de la sérotonine5-HT1B receptors mediate the antidepressant effects of selective serotonin reuptake inhibitors. - [Alain M. Gardier, Anne-Cécile Trillat, Isabelle Malagié, Denis David, Martine Hasco?t, Marie-Claude Colombel, Pascale Jolliet, Christian Jacquot, René Hen and Michel Bourin]
  • Troubles dysphoriques prémenstruels : diagnostic et traitements médicamenteuxPremenstrual dysphoric disorder: diagnostic and pharmacological treatment - [G. Benjelloun and A. Pelissolo]
  • Expose your clinical thinking - [.]
  • DRUG RESISTANCE IN BRAIN DISEASES AND THE ROLE OF DRUG EFFLUX TRANSPORTERS - [Wolfgang L?scher & Heidrun Potschka about the authors]
  • Decreased platelet [3H]paroxetine binding sites in suicide attempters - [Antonella Armani, Gino Giannaccini, Elena Di Nasso, Antonio Lucacchini and Giovanni B. Cassano]
  • Strategies to Reduce Misdiagnosis of Bipolar Depression - [Bowden CL.]
  • General principles for clinical use of repetitive transcranial magnetic stimulation (rTMS) - [Maertens de Noordhout A.]
  • Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats - [Koichi Isogawa, Minoru Fujiki, Jotaro Akiyoshi, Takashi Tsutsumi, Kensuke Kodama, Hirotaka Matsushita, Yoshihiro Tanaka and Hidenori Kobayashi]
  • Effects of Repeated High-Dose Methamphetamine on Local Cerebral Glucose Utilization in Rats - [Yn-Ho Huang1 Ph.D, Shih-Jen Tsai2,3 MD, Ting-Wen Su1 MSc and Cho-Boon Sim2 MD]
  • Remission and Relapse in the Outpatient Care of Schizophrenia Three-year Results From the Schizophrenia Outpatient Health Outcomes Study - [Haro JM, Novick D, Suarez D, Alonso J, Lépine JP, Ratcliffe M; SOHO Study Group.]
  • THE BALANCING ACT - [.]
  • DEPRESSION, ANTIDEPRESSANTS AND SUICIDALITY: A CRITICAL APPRAISAL - [Julio Licinio & Ma-Li Wong about the authors]
  • Intrafamilial Correspondences on Platelet [3H-]Paroxetine-Binding Indices in Bulimic Probands and their Unaffected First-Degree Relatives - [Howard Steiger1,2,3, Lise Gauvin4, Ridha Joober2,3, Mimi Israel1,2,3, N M K Ng Ying Kin2,3, Kenneth R Bruce1,2,3, Jodie Richardson1,5, Simon N Young2 and Julie Hakim1]
  • Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders - [Gerard J Marek1,*, Linda L Carpenter2, Christopher J McDougle3 and Lawrence H Price2]
  • Behavioral and psychophysiological characteristics of children of parents with social phobia a pilot study - [Campbell MJ, Schmidt LA, Santesso DL, Van Ameringen M, Mancini CL, Oakman JM.]
  • Post exercise hypotension is not mediated by the serotonergic system in borderline hypertensive individuals - [J R MacDonald, J M Rosenfeld, M A Tarnopolsky, C D Hogben, C S Ballantyne and J D MacDougall]
  • Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs - [Rebeca Martínez-Turrillas, Joaquín Del Río and Diana Frechilla]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 [34] 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50